Researchers closing in on genetic treatments for hereditary lung disease, vision loss

- Advertisement -


Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.
- Advertisement -

Latest articles

Related articles

error: Content is protected !!